These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
586 related articles for article (PubMed ID: 34063264)
1. New Antibiotics for Multidrug-Resistant Bacterial Strains: Latest Research Developments and Future Perspectives. Terreni M; Taccani M; Pregnolato M Molecules; 2021 May; 26(9):. PubMed ID: 34063264 [TBL] [Abstract][Full Text] [Related]
2. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli. Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199 [TBL] [Abstract][Full Text] [Related]
3. Advances in novel antibiotics to treat multidrug-resistant gram-negative bacterial infections. Matlock A; Garcia JA; Moussavi K; Long B; Liang SY Intern Emerg Med; 2021 Nov; 16(8):2231-2241. PubMed ID: 33956311 [TBL] [Abstract][Full Text] [Related]
4. New Drugs for Multidrug-Resistant Gram-Negative Organisms: Time for Stewardship. Jean SS; Gould IM; Lee WS; Hsueh PR; Drugs; 2019 May; 79(7):705-714. PubMed ID: 30972660 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Bactericidal Activity of Plazomicin and Comparators against Multidrug-Resistant Enterobacteriaceae. Thwaites M; Hall D; Shinabarger D; Serio AW; Krause KM; Marra A; Pillar C Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866876 [TBL] [Abstract][Full Text] [Related]
7. Developments on antibiotics for multidrug resistant bacterial Gram-negative infections. Voulgaris GL; Voulgari ML; Falagas ME Expert Rev Anti Infect Ther; 2019 Jun; 17(6):387-401. PubMed ID: 31006284 [No Abstract] [Full Text] [Related]
8. Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations. Zhanel GG; Lawrence CK; Adam H; Schweizer F; Zelenitsky S; Zhanel M; Lagacé-Wiens PRS; Walkty A; Denisuik A; Golden A; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA Drugs; 2018 Jan; 78(1):65-98. PubMed ID: 29230684 [TBL] [Abstract][Full Text] [Related]
9. Synergistic antibacterial effects of colistin in combination with aminoglycoside, carbapenems, cephalosporins, fluoroquinolones, tetracyclines, fosfomycin, and piperacillin on multidrug resistant Klebsiella pneumoniae isolates. Ontong JC; Ozioma NF; Voravuthikunchai SP; Chusri S PLoS One; 2021; 16(1):e0244673. PubMed ID: 33406110 [TBL] [Abstract][Full Text] [Related]
10. Recent developments in antibiotic agents for the treatment of complicated intra-abdominal infections. Lin SY; Huang CH; Ko WC; Chen YH; Hsueh PR Expert Opin Pharmacother; 2016; 17(3):339-54. PubMed ID: 26610040 [TBL] [Abstract][Full Text] [Related]
11. Vaborbactam: Spectrum of Beta-Lactamase Inhibition and Impact of Resistance Mechanisms on Activity in Enterobacteriaceae. Lomovskaya O; Sun D; Rubio-Aparicio D; Nelson K; Tsivkovski R; Griffith DC; Dudley MN Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848018 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Snydman DR; McDermott LA; Jacobus NV; Kerstein K; Grossman TH; Sutcliffe JA Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29483114 [TBL] [Abstract][Full Text] [Related]
16. Meropenem-vaborbactam: a new weapon in the war against infections due to resistant Gram-negative bacteria. Patel TS; Pogue JM; Mills JP; Kaye KS Future Microbiol; 2018 Jul; 13(9):971-983. PubMed ID: 29692218 [TBL] [Abstract][Full Text] [Related]
17. Emergence of an Extensively Drug-Resistant Klemm EJ; Shakoor S; Page AJ; Qamar FN; Judge K; Saeed DK; Wong VK; Dallman TJ; Nair S; Baker S; Shaheen G; Qureshi S; Yousafzai MT; Saleem MK; Hasan Z; Dougan G; Hasan R mBio; 2018 Feb; 9(1):. PubMed ID: 29463654 [TBL] [Abstract][Full Text] [Related]
18. Plazomicin: A Novel Aminoglycoside for the Treatment of Resistant Gram-Negative Bacterial Infections. Eljaaly K; Alharbi A; Alshehri S; Ortwine JK; Pogue JM Drugs; 2019 Feb; 79(3):243-269. PubMed ID: 30723876 [TBL] [Abstract][Full Text] [Related]
19. Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan. Hsueh PR; Chen WH; Luh KT Int J Antimicrob Agents; 2005 Dec; 26(6):463-72. PubMed ID: 16280243 [TBL] [Abstract][Full Text] [Related]
20. A novel combination therapy for multidrug resistant pathogens using chitosan nanoparticles loaded with β-lactam antibiotics and β-lactamase inhibitors. Fan P; Ma Z; Partow AJ; Kim M; Shoemaker GM; Tan R; Tong Z; Nelson CD; Jang Y; Jeong KC Int J Biol Macromol; 2022 Jan; 195():506-514. PubMed ID: 34920071 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]